Jakob W. Hansen

Copenhagen, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Exploring the Functional Impact of Individual DDX41 Variants With a Fast and Robust Cell-Based Method.

Exploring the Functional Impact of Individual DDX41 Variants With a Fast and Robust Cell-Based Method.

Journal: Human mutation

Published: December 02, 2025

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression.

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression.

Journal: Molecular oncology

Published: November 20, 2025

Outcomes and prognostic impact of trisomy 8 in acute myeloid leukemia patients treated with intensive chemotherapy.

Outcomes and prognostic impact of trisomy 8 in acute myeloid leukemia patients treated with intensive chemotherapy.

Journal: Blood cancer journal

Published: February 17, 2025

Overlapping DNA methylation changes in enhancers in clonal cytopenia of undetermined significance and myelodysplastic neoplasm patients with TET2, IDH2, or DNMT3A mutations.

Overlapping DNA methylation changes in enhancers in clonal cytopenia of undetermined significance and myelodysplastic neoplasm patients with TET2, IDH2, or DNMT3A mutations.

Journal: Haematologica

Published: April 04, 2024

Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatment.

Treatment experiences with focus on IL-6R inhibition in patients with VEXAS syndrome and a case of remission with azacytidine treatment.

Journal: Rheumatology (Oxford, England)

Published: October 12, 2023

ProGraME: A novel flow cytometry algorithm for the diagnosis of low-risk myelodysplastic syndromes in patients with cytopenia.

ProGraME: A novel flow cytometry algorithm for the diagnosis of low-risk myelodysplastic syndromes in patients with cytopenia.

Journal: European journal of haematology

Published: June 13, 2023

Frequency and Functional Characterization of RUNX1 Germline Variants in Myeloid Neoplasms.

Frequency and Functional Characterization of RUNX1 Germline Variants in Myeloid Neoplasms.

Journal: Human mutation

Published: January 25, 2023

LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome.

LEP promoter methylation in the initiation and progression of clonal cytopenia of undetermined significance and myelodysplastic syndrome.

Journal: Clinical epigenetics

Published: December 21, 2022

Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine.

Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with Guadecitabine.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 08, 2022

Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins.

Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins.

Journal: HemaSphere

Published: April 19, 2022

A predictive model for bone marrow disease in cytopenia based on noninvasive procedures.

A predictive model for bone marrow disease in cytopenia based on noninvasive procedures.

Journal: Blood advances

Published: November 18, 2021

Inflammatory Cytokine Profiles Do Not Differ Between Patients With Idiopathic Cytopenias of Undetermined Significance and Myelodysplastic Syndromes.

Inflammatory Cytokine Profiles Do Not Differ Between Patients With Idiopathic Cytopenias of Undetermined Significance and Myelodysplastic Syndromes.

Journal: HemaSphere

Published: August 09, 2021

Showing 1-12 of 38

Last Updated: 09/26/2026